PROTEASOME INHIBITORS HAVING CHYMOTRYPSIN-LIKE ACTIVITY
申请人:Lawrence Harshani
公开号:US20120142917A1
公开(公告)日:2012-06-07
Disclosed herein is the use of HLM-008182, as well as its analogues formed via in-house synthesis, as a potent proteasome inhibitors. A new method was developed for HLM-008182 through a four-step protocol and the method was further optimized to a two step protocol. The synthesis in both protocols was regioselective with TiCl
4
. The reaction was highly efficient with microwave assisted heating and THF as solvent. The modification around the molecule HLM-008182 established primary SAR, indicating that the proteasome inhibition activity was a function of the 2-side chain.
[EN] PROTEASOME INHIBITORS HAVING CHYMOTRYPSIN-LIKE ACTIVITY<br/>[FR] INHIBITEURS DE PROTÉASOME DOTÉS D'UNE ACTIVITÉ DE TYPE CHYMOTRYPSINE
申请人:H LEE MOFFITT CANCER CT AND RE
公开号:WO2010102286A2
公开(公告)日:2010-09-10
Disclosed herein is the use of HLM-008182, as well as its analogues formed via in-house synthesis, as a potent proteasome inhibitors. A new method was developed for HLM-008182 through a four-step protocol and the method was further optimized to a two step protocol. The synthesis in both protocols was regioselective with TiCl4. The reaction was highly efficient with microwave assisted heating and THF as solvent. The modification around the molecule HLM-008182 established primary SAR, indicating that the proteasome inhibition activity was a function of the 2-side chain.
Avdeenko, A. P.; Velichko, N. V.; Tolmachev, A. A., Journal of general chemistry of the USSR, 1990, vol. 60, # 7.1, p. 1339 - 1342
作者:Avdeenko, A. P.、Velichko, N. V.、Tolmachev, A. A.、Pirozhenko, V. V.、Gol'dfarb, E. I.